| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of Moricizine |
| Disease Entry |
ICD 11 |
Status |
REF |
| Arrhythmia |
BC9Z
|
Approved |
[2] |
| Long QT syndrome |
BC65.0
|
Approved |
[3] |
| Heart arrhythmia |
BC65
|
Withdrawn from market |
[4] |
|
|
|
Moricizine Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Voltage-gated sodium channel alpha Nav1.5 (SCN5A)
|
TTZOVE0
|
SCN5A_HUMAN
|
Blocker
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Maprotiline |
| Disease Entry |
ICD 11 |
Status |
REF |
| Depression |
6A70-6A7Z
|
Approved |
[5] |
| Major depressive disorder |
6A70.3
|
Approved |
[2] |
| Mixed anxiety and depressive disorder |
N.A.
|
Investigative |
[5] |
|
|
|
Maprotiline Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Norepinephrine transporter (NET)
|
TTAWNKZ
|
SC6A2_HUMAN
|
Inhibitor
|
[7] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Maprotiline Interacts with 2 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 1A2 (CYP1A2)
|
DEJGDUW
|
CP1A2_HUMAN
|
Metabolism
|
[8] |
|
Cytochrome P450 2D6 (CYP2D6)
|
DECB0K3
|
CP2D6_HUMAN
|
Metabolism
|
[8] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|